{
    "data": [
        {
            "id": "2700085",
            "type": "article",
            "attributes": {
                "publishOn": "2014-11-21T17:01:33-05:00",
                "isLockedPro": false,
                "commentCount": 5,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Perrigo Expands Partnership With 7-Eleven",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "58481",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "145438",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "4523",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2700085-perrigo-expands-partnership-with-7-eleven"
            }
        },
        {
            "id": "2472095",
            "type": "article",
            "attributes": {
                "publishOn": "2014-09-04T16:34:54-04:00",
                "isLockedPro": false,
                "commentCount": 5,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Perrigo: 4 Positive Catalysts And 2 Wildcards For FY 2015",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "58481",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "140108",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "4523",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2472095-perrigo-4-positive-catalysts-and-2-wildcards-for-fy-2015"
            }
        },
        {
            "id": "2430165",
            "type": "article",
            "attributes": {
                "publishOn": "2014-08-17T12:58:42-04:00",
                "isLockedPro": false,
                "commentCount": 8,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Perrigo Shines Again: Digging Into Perrigo Company's Q4 2014 And FY 2014 Earnings Report",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "64663",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "138757",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "4523",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2430165-perrigo-shines-again-digging-into-perrigo-companys-q4-2014-and-fy-2014-earnings-report"
            }
        },
        {
            "id": "2279453",
            "type": "article",
            "attributes": {
                "publishOn": "2014-06-20T15:19:50-04:00",
                "isLockedPro": false,
                "commentCount": 8,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Allergan Should Buy Perrigo For A Tax Inversion; Before Someone Else Does",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "64663",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "135561",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "4523",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2279453-allergan-should-buy-perrigo-for-a-tax-inversion-before-someone-else-does"
            }
        },
        {
            "id": "2263343",
            "type": "article",
            "attributes": {
                "publishOn": "2014-06-11T10:07:39-04:00",
                "isLockedPro": false,
                "commentCount": 2,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Perrigo Can Reach $200 If It Keeps Tysabri Royalties, Lot More If It Sells Them",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "64663",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "135062",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "4523",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2263343-perrigo-can-reach-200-if-it-keeps-tysabri-royalties-lot-more-if-it-sells-them"
            }
        },
        {
            "id": "2233163",
            "type": "article",
            "attributes": {
                "publishOn": "2014-05-22T11:27:17-04:00",
                "isLockedPro": false,
                "commentCount": 3,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Catalyst For Perrigo: Sale Of Tysabri Royalties",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "64663",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "134223",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "4523",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2233163-catalyst-for-perrigo-sale-of-tysabri-royalties"
            }
        }
    ]
}